re pyc14 May 2018 18:32
Tue, 28th Nov 2017 07:00
RNS Number : 6248X
Physiomics PLC
28 November 2017
Physiomics plc
("Physiomics") or ("the Company")
Completion of VT Clinical Project with Merck and announcement of Master Services Agreement
Physiomics plc (AIM: PYC) is pleased to announce that the human Virtual Tumour ("VT") project with Merck, a leading science and technology company, first announced in March 2015, has now been successfully completed and that it has today entered into a Master Services Agreement ("Agreement") with Merck. The Agreement envisages a multi-year relationship and its minimum value to Physiomics in the first twelve months will be �500,000. Physiomics believes this Agreement represents a significant milestone in the relationship between the two companies and reflects the value that it has been able to add over five years of working with this key client.
everyone was led to believe it was MERCK the big one and only... we was not told...that the 500k contract
was another CO call MERCK SERONO ... THIS CO was not mention in any RNS ...NO WONDER
SP WENT THAT CRAZY LOL'''''' smoke's and mirror's on AIM.....
WELL DONE PRO ACTIVE for sheading some light for us investors in this AIM casino
not that it make any different now ... but it's nice to know....